UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Medical Group

Patient Satisfaction

patient careUCLA Health is fully committed to providing our patients and their family members with the best possible experience as they visit our facilities and interact with our physicians, nurses and other clinical staff.  To this end, we participate in statewide collaboratives with organizations comprised of health plans, provider organizations and purchasers.  We assess our patients' experiences with the care delivered by our medical group and benchmark our performance against those of other medical groups in California.  For example, results of the Patient Assessment Survey (PAS), sponsored by the California Healthcare Reporting Initiative (CCHRI), include overall rating of care and doctor-patient interaction measures.  These results for commercially insured patients covered by a health maintenance organization (HMO) or point of service (POS) plan are reported in our patient satisfaction performance summary.  We use this information to continually improve the experiences of the patients who entrust us with their lives.

  • Overall Rating of Care
  • Doctor-Patient Interactions

For information regarding how the ratings are calculated, visit the California Office of the Patient Advocate's "About Medical Group Ratings" section.

Patient Satisfaction Performance Summary

Overall Ratings of Health Care   For the reporting period, commercially insured HMO and POS patients rated the care provided by their UCLA primary care physician as 90 on a scale of 0 (worst care) to 100 (best care), which exceeds the average performance of medical groups in California (rated as 87). The same patients gave a rating of 89 for the overall care received at UCLA, which is higher than the statewide average. UCLA's HMO/POS patients indicated they would recommend their UCLA doctor with a score of 89, which exceeds the statewide average score of 86.
Doctor - Patient Interactions  For the specified reporting period, commercially insured HMO and POS patients rated their overall interactions with their UCLA physician consistently higher than the average rating of medical groups in California.

Clinical Care

UCLA Medical Group is committed to delivering the highest quality care according to nationally recognized standards of clinical care. These standards have been established based on scientific evidence indicating that certain tests and treatment guidelines prevent development of disease, such as cancer in women, and improve outcomes for patients with chronic conditions, such as asthma, diabetes and heart disease.  A statewide collaborative of health plans, provider organizations and purchasers in California collects and publicly reports information regarding clinical care measures from participating medical groups. We use this information to continually improve the care we provide to our patients.

  • Women’s Health
  • Colorectal Cancer Screening
  • Care for Adults
  • Childhood Immunizations
  • Care for Children
  • Providing Care for Adolescents

For information regarding how the ratings are calculated, visit the California Office of the Patient Advocate’s “About Medical Group Ratings” section.

Clinical Care Performance Summary

Providing Preventative Women's Health Screenings  For the specified reporting period, 80% of UCLA Medical Group's commercially insured HMO and POS female members of all ages received a mammogram to test for breast cancer during the past two years, while 84% of these patients received a pap smear to test for cervical cancer during the past three years. Approximately 57% of commercially insured HMO and POS young female members received screenings for Chlamydia. UCLA Medical Group's screening rates are significantly better than breast cancer (76%), cervical cancer (75%) and Chlamydia (52%) screening rates of average medical groups in California.  These tests are important because with early detection, cancer and Chlamydia infection can be treated and cured most effectively.
 
 Providing Colorectal Cancer Screening For the specified reporting period, 74% of UCLA Medical Group's commercially insured HMO and POS members were appropriately screened for colorectal cancer according to national guidelines. This screening rate is significantly higher than the screening rates of average medical groups in California (53%). Colorectal cancer screening is important because with early detection, there is a much better chance that colorectal cancer can be effectively treated and cured.
   
Providing Care for Adults  

For the specified reporting period, 91% of UCLA Medical Group's commercially insured HMO and POS members with various forms of heart disease, including history of a heart attack,  had their low density lipid cholesterol (LDL) level checked in the last year; this rate is better than the average of 84% statewide. Seventy-five percent of these patients (compared to an average of 63% statewide) had their LDL cholesterol levels well controlled (test value ≤100 mg/dL). Lower levels of LDL cholesterol are associated with better outcomes in those with cardiovascular disease. Additionally, 86% of UCLA Medical Group patients received appropriate annual monitoring of chronic medications to manage their heart disease, compared to an average of 81% of patients statewide.

For the specified reporting period, UCLA Medical Group members with diabetes had screening and treatment rates that significantly exceeded the performance on average of medical groups in the state.  Ninety-one percent of members with diabetes had their blood sugar (hemoglobin A1C - HbA1C) level checked at least once in the year; 88% of these patients had well-controlled blood sugar (hemoglobin A1C - HbA1C) levels; 85% of members with diabetes had their low density lipid (LDL) cholesterol level checked at least once during the year; 53% of these patients had well-controlled cholesterol levels (≤ 100 mg/dL); and 85% of members with diabetes had their kidney function tested to help manage their disease.

For the specified reporting period, 76% of UCLA Medical Group's commercially insured HMO and POS adult patients with asthma received the specified types of medicines (anti-inflammatories) for their condition.  Forty-two percent  of patients received guideline-based treatment for acute bronchitis; antibiotics are not recommended for most cases of acute bronchitis. Eighty-five percent of UCLA's patients received guideline-based use of imaging studies in the evaluation of acute low back pain, which was slightly higher than the statewide average (78%).

 

 

Providing Childhood Immunizations 

For the specified reporting period, commercially insured HMO and POS children treated by UCLA Medical Group generally received immunization shots at higher rates than the average for all children receiving care from medical groups in California. Immunizations protect children from serious diseases, such as measles, mumps, rubella and chicken pox. Medical groups that score well in this category work collaboratively with parents to ensure that their children receive these shots.

   
Providing Care for Children 

For the specified reporting period, 73% of commercially insured HMO and POS children with asthma aged 5 to 9 years and 97% of children with asthma aged 5 to 11 years treated by UCLA Medical Group received  the specified types of medicines (anti-inflammatories) for their condition.  

For the specified reporting period, 95% of children aged 3 months to 18 years who had a simple upper respiratory infection (common cold) were not prescribed antibiotics; antibiotics are not recommended for simple upper respiratory infections. Additionally, 78% of UCLA's patients (compared to 61% statewide) received testing for pharyngitis before the use of antibiotics.

 
   
Providing Care for Adolescents For the specified period, 83% of commercially insured HMO and POS adolescents were vaccinated against meningococcal infection, 69% against pertussis (whooping cough), tetanus, and diphtheria. Both of these rates is well above the statewide average.